3 ms·
> Is your disease uncommon? Estimated at 2-3% of the world population, so 100M+ people.
by ceejayoz 4y ago
> Is your disease uncommon?
Estimated at 2-3% of the world population, so 100M+ people.
- inglor_cz 4y agoSo is the treatment something highly unusual? I am sorry to be prying such information out of you, but things with such a cost label tend to be very high-tech (e.g. tumor-invading lymphocytes etc. that need to be cultivated for each patient separately, which cannot possibly be cheap).
- ceejayoz 4y agoIt's a monoclonal antibody. I suspect it'll look cheap in comparison to life extension treatments.
- jjk166 4y agoThat's because monoclonal antibodies are targeted to a very specific protein. Polyclonal antibodies which can be used more generally are much cheaper. You're paying for the purity, not the substance.